Capital Medical University Reports Findings in Seasonal Allergic Rhinitis [Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, ...]

Media coverage

• Title	Capital Medical University Reports Findings in Seasonal Allergic Rhinitis [Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, ...]
  Media name/outlet	Daily China News
  Country/Territory	United States
  Date	2/22/24
  Persons	Yuanwei Zhang